MED19 and urinary bladder carcinoma: The expression of BMP6, a key endogenous regulator of iron metabolism, was affected by Med19, which could promote bone metastasis and invasiveness of bladder cancer (Andriopoulos Jr et al., 2009; Wen et al., 2013).